Search

Silence will use the Phase 2 result to pursue a larger trial plan and potential partner discussions.

Clean Phase 2 signals in rare cancers can unlock partnering, financing, and accelerated development paths, especially for modalities like gene silencing where delivery and durability are central investor questions.